Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1984;70:1083-1091

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Belardinelli, L.
Right arrow Articles by Berne, R. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Belardinelli, L.
Right arrow Articles by Berne, R. M.

Circulation, Vol 70, 1083-1091, Copyright © 1984 by American Heart Association


ARTICLES

Effects of adenosine and adenine nucleotides on the atrioventricular node of isolated guinea pig hearts

L Belardinelli, J Shryock, GA West, HF Clemo, JP DiMarco and RM Berne

The primary goal of this study was to determine whether the slowing of atrioventricular (AV) conduction by ATP is caused by ATP per se or is mediated by adenosine formed from ATP degradation. We assessed the effects of ATP, beta, gamma-methylene ATP, ADP, AMP, and adenosine on AV conduction time in the isolated perfused guinea pig heart. The cardiac effluent was collected and analyzed for its content of adenine nucleotides and nucleosides. Perfused ATP was rapidly and almost completely broken down to AMP and adenosine; only 2.5 +/- 0.5% of the infused ATP was recoverable in the effluent. A significant correlation was found between the effluent concentration of adenosine and atria-to- His bundle (A-H) conduction time. Compounds that altered the effect of adenosine on A-H conduction likewise altered the effect of ATP: (1) aminophylline, a competitive antagonist of adenosine, antagonized the ATP-induced A-H prolongation; (2) adenosine deaminase, the enzyme responsible for the deamination of adenosine to inosine, reduced the effect of ATP by 82%; (3) the adenosine transport blockers NBMPR and dipyridamole markedly enhanced the effect of ATP; and (4) EHNA, an inhibitor of adenosine deaminase, potentiated the effect of ATP. Furthermore, the less hydrolyzable ATP analog, beta, gamma-methylene ATP, was less potent than ATP in causing A-H prolongation. We conclude that the adenosine-like action of ATP on the guinea pig AV node requires that ATP first be degraded to adenosine.


This article has been cited by other articles:


Home page
QJMHome page
S.W. Parry, T. Chadwick, J.C. Gray, R.S. Bexton, M. Tynan, J.P. Bourke, and S. Nath
The intravenous adenosine test: a new test for the identification of bradycardia pacing indications? A pilot study in subjects with bradycardia pacing indications, vasovagal syncope and controls
QJM, July 1, 2009; 102(7): 461 - 468.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
M. E. Mangoni and J. Nargeot
Genesis and Regulation of the Heart Automaticity
Physiol Rev, July 1, 2008; 88(3): 919 - 982.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
S. J. Swoap, M. Rathvon, and M. Gutilla
AMP does not induce torpor
Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2007; 293(1): R468 - R473.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
S. W. Parry, S. Nath, J. P. Bourke, R. S. Bexton, and R. A. Kenny
Adenosine test in the diagnosis of unexplained syncope: marker of conducting tissue disease or neurally mediated syncope?
Eur. Heart J., June 2, 2006; 27(12): 1396 - 1400.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
J. Neumann, P. Boknik, F. Begrow, G. Hanske, I. Justus, M. Mat'us, U. Reinke, G.P. Matherne, and W. Schmitz
Altered signal transduction in cardiac ventricle overexpressing A1-adenosine receptors
Cardiovasc Res, December 1, 2003; 60(3): 529 - 537.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
M. W. Gorman, K. Ogimoto, M. V. Savage, K. A. Jacobson, and E. O. Feigl
Nucleotide coronary vasodilation in guinea pig hearts
Am J Physiol Heart Circ Physiol, August 7, 2003; 285(3): H1040 - H1047.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
G. Vassort
Adenosine 5'-Triphosphate: a P2-Purinergic Agonist in the Myocardium
Physiol Rev, April 1, 2001; 81(2): 767 - 806.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
T. Yamamoto, Y. Habuchi, M. Nishio, J. Morikawa, and H. Tanaka
P2 purinoceptors contribute to ATP-induced inhibition of L-type Ca2+ current in rabbit atrial myocytes
Cardiovasc Res, January 1, 1999; 41(1): 166 - 174.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
D. M. Dennis, M.J. P. Raatikainen, J. R. Martens, and L. Belardinelli
Modulation of Atrioventricular Nodal Function by Metabolic and Allosteric Regulators of Endogenous Adenosine in Guinea Pig Heart
Circulation, November 15, 1996; 94(10): 2551 - 2559.
[Abstract] [Full Text]


Home page
ANGIOLOGYHome page
S. Nanto, T. Masuyama, M. Hori, T. Shimonagata, T. Ohara, and S. Kubori
Zero Flow Pressure in Human Coronary Circulation
Angiology, February 1, 1996; 47(2): 115 - 122.
[Abstract] [PDF]